Skip to content
OpenCapital
Get started

Benitec Biopharma Inc. BNTC Q1 2026 earnings

Reported May 14, 2026 · Before market open

EPS-$0.24Beat by $0.03
Revenue estimate$4.6M
EPS estimate-$0.27

Next report

Sep 28, 2026 (in 2 months)
EPS estimate-$0.25

Versus estimates

Revenue

Q2 2025$556.0K

Diluted EPS

Q1 2026-$0.24Beat by $0.03
Q4 2025-$0.26Miss by $0.03Q3 2025-$0.22Beat by $0.13Q2 2025-$0.42Miss by $0.14Q1 2025-$0.24Beat by $0.12Q4 2024-$0.36Beat by $0.64

Ask the moment Benitec Biopharma Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Benitec Biopharma Inc. report Q1 2026 earnings?
Benitec Biopharma Inc. (BNTC) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Benitec Biopharma Inc.'s Q1 2026 revenue and EPS?
Benitec Biopharma Inc. reported eps of $-0.24 for Q1 2026.
Did Benitec Biopharma Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.27 by $0.03.
How did Benitec Biopharma Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 0.0% from $-0.24.
Where can I find Benitec Biopharma Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-222879) and the 10-Q periodic report (0001193125-26-222885) directly on SEC EDGAR. The filing index links above go to sec.gov.